Eyenuk
Mentions
1
Across all reports
Quality Score
15/ 100
New
First Seen
Jul 31, 2026
Indexed in atlas
Last Seen
7h ago
Most recent reference
Positioning
Synthesized from 1 mentionEyenuk's EyeArt is an FDA-cleared AI system for autonomous detection of diabetic retinopathy, with CE marking for Europe. It supports both cloud and on-premise deployment, and its platform is expanding to detect glaucoma, AMD, and other conditions. It offers a per-screening pricing model and integrates with existing fundus cameras.
Strengths
4 cited- FDA and CE clearances
- Multi-disease detection roadmap
- Cloud and on-premise options
- Global distribution
Weaknesses
3 cited- Hardware integration required
- Not fully autonomous for all diseases
- Pricing not transparent
Recent mentions
Showing 1 of 1- direct7h ago
AI-Powered Retinal Disease Screening System
poweredretinaldiseasescreeningsystem
Validate something like Eyenuk
Use Eyenuk as a starting point and let Unycorn map adjacent opportunities, underserved segments, and feature gaps worth pursuing.